Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
The clinical effects of the oral beta 1 partial agonist, prenalterol, were investigated in 37 patients (29 male, eight female; mean age 57 years) with chronic ischaemic left ventricular failure using a placebo controlled randomised double blind protocol over six months. All patients were limited by...
Guardado en:
| Publicado en: | Br Heart J |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
1985
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481741/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2857088/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.53.2.208 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|